Asian Tribune Your Multilingual Newspaper covering World and local news News
Drug maker Lupin on Wednesday said it has entered into a distribution agreement with Medis for Lupin’s orphan drug NaMuscla (mexiletine). Medis will commercialize NaMuscla for the symptomatic treatment of myotonia in adults with non-dystrophic myotonic (NDM) disorders in Central and Eastern European countries. Under the agreement, Medis will initially …
Read More »
Breaking News
- May home sales down 5.1%, but CREA sees positive momentum
- Zelenskyy, G7 leaders work to persuade Trump ‘tide is turning for Ukraine’
- Conservatives pitch legalizing some psychedelics with bill to revamp Canada’s drug laws
- Hot mic moment at G7 catches Carney, Trump talking about Chinese EVs
- CBC will no longer show NHL games as sublicense with rights-holder Rogers Sportsnet ends